FDA NDC Directory · JSON-LD · Markdown

Cisatracurium Besylate

NDC 31722-313 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerCamber Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA212432
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsCISATRACURIUM BESYLATE (2 mg/mL)
Marketing started20260504
Package count1

External sources

Source: openFDA. Public-domain (CC0).